- Q1 2024 Supernus Pharmaceuticals Inc Earnings Call TranscriptMay 08, 2024€28.8 (+2.13%)Earnings
- Q4 2023 Supernus Pharmaceuticals Inc Earnings Call TranscriptFeb 27, 2024€27 (+1.50%)Earnings
- Q3 2023 Supernus Pharmaceuticals Inc Earnings Call TranscriptNov 08, 2023€22.2Earnings
- Supernus Pharmaceuticals Inc R&D Day TranscriptOct 18, 2023
- Q2 2023 Supernus Pharmaceuticals Inc Earnings Call TranscriptAug 08, 2023€29 (-0.68%)Earnings
- Supernus Pharmaceuticals Inc at Jefferies Healthcare Conference TranscriptJun 07, 2023
- Q1 2023 Supernus Pharmaceuticals Inc Earnings Call TranscriptMay 09, 2023€33.2 (+0.61%)Earnings
- Q4 2022 Supernus Pharmaceuticals Inc Earnings Call TranscriptFeb 28, 2023Earnings
- Q3 2022 Supernus Pharmaceuticals Inc Earnings Call TranscriptNov 08, 2022€34.4 (+1.18%)Earnings
- Q2 2022 Supernus Pharmaceuticals Inc Earnings Call TranscriptAug 04, 2022€31.2Earnings
- Q1 2022 Supernus Pharmaceuticals Inc Earnings Call TranscriptMay 09, 2022€25.8 (-2.27%)Earnings
- Preliminary Q4 2021 Supernus Pharmaceuticals Inc Earnings Call TranscriptFeb 28, 2022€27 (-4.93%)Earnings
- Q3 2021 Supernus Pharmaceuticals Inc Earnings Call TranscriptNov 03, 2021€25.6 (-0.78%)Earnings
- Supernus Pharmaceuticals Inc Acquisition of Adamas Pharmaceuticals Inc - M&A Call TranscriptOct 11, 2021
- Supernus Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 15, 2021
- Q2 2021 Supernus Pharmaceuticals Inc Earnings Call TranscriptAug 04, 2021€22.6 (+0.89%)Earnings
- Q1 2021 Supernus Pharmaceuticals Inc Earnings Call TranscriptMay 05, 2021€25 (-1.57%)Earnings
- Supernus Pharmaceuticals Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 03, 2021
- Q4 2020 Supernus Pharmaceuticals Inc Earnings Call TranscriptFeb 25, 2021€26 (+9.24%)Earnings
- Supernus Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- Q3 2020 Supernus Pharmaceuticals Inc Earnings Call TranscriptNov 04, 2020€17.5 (+12.18%)Earnings
- Supernus Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 16, 2020
- Q2 2020 Supernus Pharmaceuticals Inc Earnings Call TranscriptAug 19, 2020€21.4 (+3.88%)Earnings
- Q1 2020 Supernus Pharmaceuticals Inc Earnings Call TranscriptMay 06, 2020€20.2Earnings
- Supernus Pharmaceuticals Inc to Acquire the CNS portfolio of Us WorldMeds LLC - Conference Call TranscriptApr 29, 2020
- Q4 2019 Supernus Pharmaceuticals Inc Earnings Call TranscriptFeb 26, 2020€17.8 (-18.35%)Earnings
- Supernus Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 15, 2020
- Q3 2019 Supernus Pharmaceuticals Inc Earnings Call TranscriptNov 06, 2019€19.8 (-25.56%)Earnings
- Supernus Pharmaceuticals Inc at Morgan Stanley Healthcare Conference TranscriptSep 11, 2019
- Q2 2019 Supernus Pharmaceuticals Inc Earnings Call TranscriptAug 07, 2019€26.27 (-7.63%)Earnings
- Q1 2019 Supernus Pharmaceuticals Inc Earnings Call TranscriptMay 08, 2019€28.06 (-17.06%)Earnings
- Supernus Pharmaceuticals Inc Investor Day TranscriptApr 16, 2019
- Supernus Pharmaceuticals Inc to Discuss the SPN-812 Phase III Topline Results - Conference Call TranscriptMar 28, 2019
- Supernus Pharmaceuticals Inc at Cowen Health Care Conference TranscriptMar 13, 2019
- Q4 2018 Supernus Pharmaceuticals Inc Earnings Call TranscriptFeb 27, 2019€33.9 (+4.12%)Earnings
Supernus Pharmaceuticals Inc at Jefferies Healthcare Conference Transcript
Hi, everyone. We're going to get started on our next session. I'm Andrew Tsai, senior biotech analyst here at Jefferies. And it's my pleasure to have Supernus joining us today. I have Jack Khattar, CEO. So welcome, Jack.
Thank you. Thanks for having me.
Jack, so for those in the audience who might be less familiar with Supernus, maybe give us a background about the company. Any opening remarks you'd like to make and then we can talk about catalysts to look forward to potentially in the next six or four months.
Again, good afternoon, everyone. And thanks for coming here. Just a quick reminder, I will be making forward-looking statements, so please check the risk factors associated with the business in our SEC filings.
So as a very brief background for those
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)